1. Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinoline carboxylic acid sodium salt], against experimental tumors;Dexter;Cancer Res,1985
2. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinoline carboxylic acid sodium salt (NSC 368390): Inhibition of de novo pyrimidine nucleotide biosynthesis;Chen;Cancer Res,1986
3. Inhibition of pyrimidine de novo synthesis by DuP 785 (NSC 368390);Peters;Invest New Drugs,1987
4. Inhibition of L1210 mitochondrial dihydroorotate dehydrogenase by DuP 785 (6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinoline carboxylic acid sodium salt);Chen,1987
5. Quinoline carboxylic acids: A new class of inhibitors of dihydroorotate dehydrogenase;Chen,1987